The Resource Alcohol and drug misuse : a Cochrane handbook, Iosief Abraha, Cristina Cusi

Alcohol and drug misuse : a Cochrane handbook, Iosief Abraha, Cristina Cusi

Label
Alcohol and drug misuse : a Cochrane handbook
Title
Alcohol and drug misuse
Title remainder
a Cochrane handbook
Statement of responsibility
Iosief Abraha, Cristina Cusi
Creator
Contributor
Subject
Genre
Language
eng
Member of
Cataloging source
DNLM/DLC
http://library.link/vocab/creatorName
Abraha, Iosief
Index
index present
LC call number
RC564.15
LC item number
.A27 2012
Literary form
non fiction
Nature of contents
bibliography
NLM call number
WM 270 A159a 2012
http://library.link/vocab/relatedWorkOrContributorName
  • Cusi, Cristina
  • Cochrane Collaboration
Series statement
Cochrane handbook
http://library.link/vocab/subjectName
  • Substance abuse
  • Substance abuse
  • Substance-Related Disorders
  • Early Medical Intervention
  • Social Support
  • Comparative Effectiveness Research
Label
Alcohol and drug misuse : a Cochrane handbook, Iosief Abraha, Cristina Cusi
Instantiates
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • ch. 3
  • Alcoholics Anonymous and other 12-step programmes for alcohol dependence
  • ch. 4
  • Mentoring adolescents to prevent substance use disorders
  • ch. 5
  • Universal school-based prevention programmes for alcohol misuse in young people
  • ch. 6
  • Universal multicomponent prevention programmes for alcohol misuse in young people
  • ch. 7
  • Universal family-based prevention programmes for alcohol misuse in young people
  • Machine generated contents note:
  • ch. 8
  • Social norms interventions to reduce alcohol misuse in university or college students
  • ch. 9
  • Psychosocial interventions for women enrolled in alcohol treatment during pregnancy
  • Pharmacological interventions
  • ch. 10
  • Benzodiazepines for alcohol withdrawal
  • ch. 11
  • pt. 1
  • Alcohol
  • Psychosocial interventions
  • ch. 1
  • Effectiveness of brief alcohol interventions in primary care populations
  • ch. 2
  • Brief interventions for heavy alcohol users admitted to general hospital wards
  • ch. 15
  • Psychotropic analgesic nitrous oxide for alcohol withdrawal
  • ch. 16
  • Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal
  • ch. 17
  • Opioid antagonists for alcohol dependence
  • ch. 18
  • Pharmacologic interventions for pregnant women enrolled in alcohol treatment
  • pt. 2
  • Drugs
  • Psychosocial interventions
  • ch. 19
  • School-based prevention for illicit substance use disorders
  • ch. 20
  • Interventions for prevention of substance use disorders by young people delivered in non-school settings
  • ch. 21
  • Case management for persons with substance use disorders
  • ch. 22
  • Motivational interviewing for substance use disorders
  • ch. 23s for alcohol withdrawal
  • Anticonvulsants for alcohol withdrawal
  • ch. 11
  • ch. 12
  • Acamprosate for alcohol dependence
  • ch. 13
  • Badofen for alcohol withdrawal
  • ch. 14
  • Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse
  • Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders
  • ch. 27
  • Antidepressants for cocaine dependence
  • ch. 28
  • Antipsychotic medications for cocaine dependence
  • ch. 29
  • Anticonvulsants for cocaine dependence
  • ch. 30
  • Dopamine agonists for cocaine dependence
  • ch. 31
  • Disulfiram for the treatment of cocaine dependence
  • ch. 32
  • Efficacy of psychostimulant drugs for cocaine dependence
  • ch. 33
  • Auricular acupuncture for cocaine dependence
  • Opioid dependence
  • ch. 34
  • Psychosocial treatment for opiate dependence
  • ch. 35rs
  • ch. 23s for alcohol withdrawal
  • Therapeutic communities for substance use disorders
  • ch. 11
  • ch. 24
  • Interventions for drug-using offenders in the courts, secure establishments and the community
  • ch. 25
  • Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions
  • Cocaine dependence
  • ch. 26
  • ch. 39
  • Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
  • ch. 40
  • Methadone at tapered doses for the management of opioid withdrawal
  • ch. 41
  • Methadone maintenance at different dosages for opioid dependence
  • ch. 42
  • Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
  • ch. 43
  • Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
  • ch. 44
  • Opioid antagonists with minimal sedation for opioid withdrawal
  • ch. 45h. 23s for alcohol withdrawal
  • ch. 11
  • Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
  • ch. 36
  • Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
  • ch. 37
  • Alpha2-adrenergic agonists for the management of opioid withdrawal
  • ch. 38
  • Buprenorphine for the management of opioid withdrawal
  • ch. 49
  • Detoxification treatments for opiate-dependent adolescents
  • ch. 50
  • Maintenance treatments for opiate-dependent adolescents
  • ch. 51
  • Maintenance agonist treatments for opiate-dependent pregnant women
  • ch. 52
  • Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
  • ch. 53
  • Inpatient versus other settings for detoxification for opioid dependence
  • ch. 54
  • Psychotherapeutic interventions for cannabis use or dependence in outpatient settings
  • ch. 55
  • Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
  • ch. 56
  • Treatment for amphetamine dependence
  • ch. 57l
  • ch. 11
  • Oral naltrexone maintenance treatment for opioid dependence
  • ch. 46
  • Sustained-release naltrexone for opioid dependence
  • ch. 47
  • Heroin maintenance for chronic heroin-dependent individuals
  • ch. 48
  • LAAM maintenance versus methadone maintenance for heroin dependence
  • Treatment for amphetamine withdrawal
  • ch. 58
  • Treatment for amphetamine psychosis
  • ch. 59
  • Treatment for methaqualone dependence in adults
Dimensions
22 cm.
Extent
xii, 156 p.
Isbn
9780470659694
Isbn Type
(pbk.)
Lccn
##2012020172
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
  • (OCoLC)794228008
  • (OCoLC)ocn794228008
Label
Alcohol and drug misuse : a Cochrane handbook, Iosief Abraha, Cristina Cusi
Publication
Bibliography note
Includes bibliographical references and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • ch. 3
  • Alcoholics Anonymous and other 12-step programmes for alcohol dependence
  • ch. 4
  • Mentoring adolescents to prevent substance use disorders
  • ch. 5
  • Universal school-based prevention programmes for alcohol misuse in young people
  • ch. 6
  • Universal multicomponent prevention programmes for alcohol misuse in young people
  • ch. 7
  • Universal family-based prevention programmes for alcohol misuse in young people
  • Machine generated contents note:
  • ch. 8
  • Social norms interventions to reduce alcohol misuse in university or college students
  • ch. 9
  • Psychosocial interventions for women enrolled in alcohol treatment during pregnancy
  • Pharmacological interventions
  • ch. 10
  • Benzodiazepines for alcohol withdrawal
  • ch. 11
  • pt. 1
  • Alcohol
  • Psychosocial interventions
  • ch. 1
  • Effectiveness of brief alcohol interventions in primary care populations
  • ch. 2
  • Brief interventions for heavy alcohol users admitted to general hospital wards
  • ch. 15
  • Psychotropic analgesic nitrous oxide for alcohol withdrawal
  • ch. 16
  • Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal
  • ch. 17
  • Opioid antagonists for alcohol dependence
  • ch. 18
  • Pharmacologic interventions for pregnant women enrolled in alcohol treatment
  • pt. 2
  • Drugs
  • Psychosocial interventions
  • ch. 19
  • School-based prevention for illicit substance use disorders
  • ch. 20
  • Interventions for prevention of substance use disorders by young people delivered in non-school settings
  • ch. 21
  • Case management for persons with substance use disorders
  • ch. 22
  • Motivational interviewing for substance use disorders
  • ch. 23s for alcohol withdrawal
  • Anticonvulsants for alcohol withdrawal
  • ch. 11
  • ch. 12
  • Acamprosate for alcohol dependence
  • ch. 13
  • Badofen for alcohol withdrawal
  • ch. 14
  • Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse
  • Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders
  • ch. 27
  • Antidepressants for cocaine dependence
  • ch. 28
  • Antipsychotic medications for cocaine dependence
  • ch. 29
  • Anticonvulsants for cocaine dependence
  • ch. 30
  • Dopamine agonists for cocaine dependence
  • ch. 31
  • Disulfiram for the treatment of cocaine dependence
  • ch. 32
  • Efficacy of psychostimulant drugs for cocaine dependence
  • ch. 33
  • Auricular acupuncture for cocaine dependence
  • Opioid dependence
  • ch. 34
  • Psychosocial treatment for opiate dependence
  • ch. 35rs
  • ch. 23s for alcohol withdrawal
  • Therapeutic communities for substance use disorders
  • ch. 11
  • ch. 24
  • Interventions for drug-using offenders in the courts, secure establishments and the community
  • ch. 25
  • Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions
  • Cocaine dependence
  • ch. 26
  • ch. 39
  • Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
  • ch. 40
  • Methadone at tapered doses for the management of opioid withdrawal
  • ch. 41
  • Methadone maintenance at different dosages for opioid dependence
  • ch. 42
  • Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
  • ch. 43
  • Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal
  • ch. 44
  • Opioid antagonists with minimal sedation for opioid withdrawal
  • ch. 45h. 23s for alcohol withdrawal
  • ch. 11
  • Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
  • ch. 36
  • Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
  • ch. 37
  • Alpha2-adrenergic agonists for the management of opioid withdrawal
  • ch. 38
  • Buprenorphine for the management of opioid withdrawal
  • ch. 49
  • Detoxification treatments for opiate-dependent adolescents
  • ch. 50
  • Maintenance treatments for opiate-dependent adolescents
  • ch. 51
  • Maintenance agonist treatments for opiate-dependent pregnant women
  • ch. 52
  • Pharmacological treatment for depression during opioid agonist treatment for opioid dependence
  • ch. 53
  • Inpatient versus other settings for detoxification for opioid dependence
  • ch. 54
  • Psychotherapeutic interventions for cannabis use or dependence in outpatient settings
  • ch. 55
  • Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
  • ch. 56
  • Treatment for amphetamine dependence
  • ch. 57l
  • ch. 11
  • Oral naltrexone maintenance treatment for opioid dependence
  • ch. 46
  • Sustained-release naltrexone for opioid dependence
  • ch. 47
  • Heroin maintenance for chronic heroin-dependent individuals
  • ch. 48
  • LAAM maintenance versus methadone maintenance for heroin dependence
  • Treatment for amphetamine withdrawal
  • ch. 58
  • Treatment for amphetamine psychosis
  • ch. 59
  • Treatment for methaqualone dependence in adults
Dimensions
22 cm.
Extent
xii, 156 p.
Isbn
9780470659694
Isbn Type
(pbk.)
Lccn
##2012020172
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
  • (OCoLC)794228008
  • (OCoLC)ocn794228008

Library Locations

  • African Studies LibraryBorrow it
    771 Commonwealth Avenue, 6th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Alumni Medical LibraryBorrow it
    72 East Concord Street, Boston, MA, 02118, US
    42.336388 -71.072393
  • Astronomy LibraryBorrow it
    725 Commonwealth Avenue, 6th Floor, Boston, MA, 02445, US
    42.350259 -71.105717
  • Fineman and Pappas Law LibrariesBorrow it
    765 Commonwealth Avenue, Boston, MA, 02215, US
    42.350979 -71.107023
  • Frederick S. Pardee Management LibraryBorrow it
    595 Commonwealth Avenue, Boston, MA, 02215, US
    42.349626 -71.099547
  • Howard Gotlieb Archival Research CenterBorrow it
    771 Commonwealth Avenue, 5th Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Mugar Memorial LibraryBorrow it
    771 Commonwealth Avenue, Boston, MA, 02215, US
    42.350723 -71.108227
  • Music LibraryBorrow it
    771 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350723 -71.108227
  • Pikering Educational Resources LibraryBorrow it
    2 Silber Way, Boston, MA, 02215, US
    42.349804 -71.101425
  • School of Theology LibraryBorrow it
    745 Commonwealth Avenue, 2nd Floor, Boston, MA, 02215, US
    42.350494 -71.107235
  • Science & Engineering LibraryBorrow it
    38 Cummington Mall, Boston, MA, 02215, US
    42.348472 -71.102257
  • Stone Science LibraryBorrow it
    675 Commonwealth Avenue, Boston, MA, 02445, US
    42.350103 -71.103784
Processing Feedback ...